Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
McCarthy LH, Bigal ME, Katz M, Derby C, Lipton RB
The biotech firm Metsera, which is developing a once-monthly GLP-1 injection, became the object of a bidding war between Pfizer and Novo Nordisk, with Pfizer emerging as the winner
Caussy, C
Endocrinology 149 (8), 40594068
While prior large-scale studies earlier in 2024 did not find an association between GLP-1 receptor agonists and retinopathy, this recent case series suggests that a subset of patients may be vulnerable to optic nerve damage and other vision complications [1,2]
US$ 21.32
US$ 27.01
US$ 22.13
US$ 29.19
